zacks.com / Page 3

Silver's 114.8% YTD surge is outpacing gold as deficits persist and demand strengthens, with FNLPF, HL and AG positioned to ride momentum into 2026.

BRK.B and MET remain resilient amid rate cuts and rising climate risks, but one outpaces the other in terms of ROE and growth.

VST's growth strategy gains traction as falling interest rates lower costs and boost demand for clean power.

BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.

FTNT's Unified SIEM adoption lifts services growth and billings, but competition and higher SIEM costs test whether momentum can last.

CLX tests its pricing power as consumers trade down, promotions rise, and margins stay under pressure in a tightening demand environment.

TGT's Fun 101 reinvents Hardlines into a traffic driver, delivering Q3 growth led by toys and double-digit gains in music and games.

Today's Unemployment Rate is the fifth straight month higher, assuming October does not remain a blank space.

Ongoing pressures on margins and housing affordability remain key concerns.

Sanofi shares slide after the FDA again delays its review of its MS drug tolebrutinib, and a phase III study fails to hit its primary endpoint.